Louisiana State University Health Sciences Center Shreveport
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, Louisiana State University Health Sciences Center Shreveport sits in the top decile of US sponsors by registered trial count (#434 of 15,742 sponsors by registered trial count).
Louisiana State University Health Sciences Center Shreveport: 40 sponsored US clinical trials, 3 recruiting.
Louisiana State University Health Sciences Center Shreveport sponsors 40 registered US clinical trials on ClinicalTrials.gov, 3 of them currently recruiting, and 22 completed. 2 of these trials are in Phase 3-4 (later-stage) and 9 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Muscle Activation, with 1 trials.
Top-decile sponsor footprint
Louisiana State University Health Sciences Center Shreveport ranks in the top decile of sponsors by registered trial count (#434 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
22 of 33 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (66.7%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
40 total, page 1 of 1
Effect of Rapid Heat Stress on Firefighters Musculoskeletal Injury Risk
NCT06442956
Impact of Heat on Dual Task Performance
NCT07629414
Lumateperone for the Improvement of Apathy in Patients With Psychotic Symptoms.
NCT06482554
Gluteal Activation Plus Movement Retraining
NCT07293039
The PRIME-CRC Trial to Promote CRC Screening in Rural Communities
NCT04313114
Plasma Hydrogen Sulfide as a Biomarker for Alzheimer's Disease and Related Dementias
NCT05060848
Ankle-Brachial Index Changes Post Exercise and Its Effects on Patient-Centered Outcomes and Gait
NCT07637396
Impact of the Wingate Test on Post-activation Potentiation
NCT06779409
Effect of Sequencing on Outcome Measures
NCT06445491
Hip Activation vs. Hip Activation + Core Stabilization
NCT06260306
Impact of Hip Activation Compared to Hip Plus Balance Training on the Forward-Step-Down Test
NCT06298903
Hip Activation and FSDT
NCT05642065
Comparison of Training Load With/Out Blood Flow Restriction Training in Rheumatoid Populations
NCT04309227
Optimization of Blood Levels of 25(OH)-Vitamin D in African Americans
NCT04939792
Muscle Activity and Kinematic Changes With Dry Needling
NCT04295200
Core Activation and Stabilization for Knee OA
NCT03776981
The Effect of Fatigue on the Forward-Step-Down Test
NCT03495752
Effect of TA Contraction on Gait in Patients With Knee OA
NCT03513094
Community and Physician Perspectives Regarding Male Youth Human Papillomavirus (HPV) Disease and Vaccination
NCT02897232
Health Literacy Interventions to Overcome Disparities in CRC Screening
NCT02360605
Impact of Arterial Stiffness and Central Aortic Blood Pressure on Kidney Transplant Outcomes
NCT02000869
Measurement of Distinct Biological Pools of Hydrogen Sulfide in Women With Cardiovascular Disease
NCT02180074
Sinonasal Gas Exchange Dynamics
NCT01671098
Application of Indocyanine Green Angiography for Closed Operative Calcaneus Fractures
NCT01693484
Hydrogen Sulfide and Peripheral Arterial Disease
NCT01407172
Curcumin Biomarker Trial in Head and Neck Cancer
NCT01160302
Induction Chemo Then Concurrent Chemoradiotherapy With Cetuximab in Locally Advanced Head and Neck Squamous Cell Cancer
NCT01326923
Effectiveness Study of Santyl Ointment to Treat Pressure Ulcers
NCT01208220
Calciuric Effect and Cyclic Parenteral Nutrition in Preterm Infants
NCT00711763
Study of Polyphenon E in Addition to Erlotinib in Advanced Non Small Cell Lung Cancer
NCT00707252
Effects of Micronutrient (Chromium) Supplementation on Diabetes
NCT01709123
Early Intervention in Mild Cognitive Impairment (MCI) With Curcumin + Bioperine
NCT00595582
Green Tea Extract and Prostate Cancer
NCT00676780
A Study of the Effect of Polyphenon E (Green Tea Extract) on Breast Cancer Progression
NCT00676793
Safety and Efficacy Study of Doxycycline in Combination With Interferon-B-1a to Treat Multiple Sclerosis
NCT00246324
Early Detection of Mild Cognitive Impairment in Individual Patients
NCT00243451
Cognitive Improvement With Aripiprazole (Abilify) in Patients With Schizophrenia (BMS)
NCT00211302
Cognitive Improvement With Aripiprazole (Abilify) in Patients With Schizophrenia (SFBRI)
NCT00211380
Repeated Bone Marrow Transplantation in Treating Women With Advanced Breast Cancer
NCT00003086
Chemotherapy Plus Bone Marrow Transplantation in Treating Patients With Metastatic Melanoma
NCT00003060
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 5 |
| Phase 2 | 4 |
| Phase 3 | 1 |
| Phase 4 | 1 |
Therapeutic Areas
What is open in the Louisiana State University Health Sciences Center Shreveport pipeline
3 recruiting of 40 indexed (8% open); 22 completed (55%).
Phase mix: 2 late (III/IV) vs 9 early (I/II) (early-phase heavy).
Top condition: Muscle Activation (1 trial), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
Louisiana State University Health Sciences Center Shreveport: open-pipeline peers nationwide
Peers matched on 40 registered trials and 8% open enrollment, not the therapeutic-area sidebar.
Louisiana State University Health Sciences Center Shreveport sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 40 trials (± recruiting share)
- Baptist Health South Florida · 40 trials · 43% recruiting
- BTL Industries · 40 trials · 8% recruiting
- Celgene Corporation · 40 trials · 0% recruiting
- Harvard School of Public Health (HSPH) · 40 trials · 3% recruiting
Sponsors near 8% open enrollment (± trial volume)
- Intuitive Surgical · 8% recruiting · 40 trials
- University of Kansas · 8% recruiting · 66 trials
- Akron Children's Hospital · 7% recruiting · 27 trials
- AVEO Pharmaceuticals · 7% recruiting · 27 trials
Related
What to do with this Louisiana State University Health Sciences Center Shreveport page
40 registered trials is a research-attention snapshot, not an endorsement of Louisiana State University Health Sciences Center Shreveport or any single study.
- 3 of Louisiana State University Health Sciences Center Shreveport's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Muscle Activation is the condition Louisiana State University Health Sciences Center Shreveport studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Muscle Activation trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Louisiana State University Health Sciences Center Shreveport pipeline card: 40 registered trials from official public datasets.Report a data error.